Stock comparison
Johnson & Johnson
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
JNJ
Johnson & Johnson
Market cap
$564.11B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | JNJ | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 62C | 69B | MTD |
| Benjamin Graham | 68B | 65B | JNJ |
| Philip Fisher | 61C | 63C | MTD |
| Peter Lynch | 65B | 66B | MTD |
| Joel Greenblatt | 47D | 68B | MTD |
| Charlie Munger | 61C | 74B | MTD |
| Terry Smith | 54C | 70B | MTD |
Side-by-side metrics
| Metric | JNJ | MTD |
|---|---|---|
| Market cap | $564.11B | $22.29B |
| P/E (TTM) | 26.7x | 25.3x |
| EV/EBIT | 21.5x | 21.6x |
| ROIC (TTM) | 13.6% | 36.09% |
| Gross margin | 69.12% | 57.79% |
| Net margin | 21.83% | 21.4% |
| Revenue CAGR 5y | 4.58% | 2.01% |
| EPS CAGR 5y | 8.6% | 6.12% |
| Debt / Equity | 0.2x | - |
| Dividend yield | 2.26% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JNJ leads on
- Dividend yield2.26%vs 0.0%+100%
- Market cap$564.11Bvs $22.29B+96%
- Revenue CAGR 5y4.58%vs 2.01%+56%
- EPS CAGR 5y8.6%vs 6.12%+29%
MTD leads on
- Debt / Equity-vs 0.2x+100%
- ROIC (TTM)36.09%vs 13.6%+62%
- P/E (TTM)25.3xvs 26.7x+5%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.